Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-14-044717
Filing Date
2014-07-24
Accepted
2014-07-24 16:33:35
Documents
1
Period of Report
2014-07-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v384641_3.html 3  
1 OWNERSHIP DOCUMENT v384641_3.xml 3 1546
  Complete submission text file 0001144204-14-044717.txt   3131
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE MEADOWLANDS PLAZA EAST RUTHERFORD NJ 07073
Business Address
Yanai Shlomo (Reporting) CIK: 0001562645 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33357 | Film No.: 14991675